2m 2m 2m 2m 2m 2m 2m
MILESTONE PHARMA (MIST)
NASDAQ
$1.34+$0.03 (+2.69%)
Price as of Jun 23, 2026 7:48 PM EDT- $163.1MMarket Cap
- -27.37%1-Year Change
- BiotechnologyIndustry
MILESTONE PHARMA (MIST)
$1.34+$0.03 (+2.69%)
MIST | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.30 | ||
Change | -$0.01 (-0.76%) | ||
Open | $1.30 | ||
High | $1.36 | ||
Low | $1.28 | ||
Previous Close | $1.31 | ||
Volume | 1,433,908 | ||
30-Day Average Volume | 1,314,584 | ||
1-Week Change | 0.78% | ||
1-Month Change | -7.80% | ||
1-Year Change | -27.37% | ||
3-Year Change | -58.73% | ||
5-Year Change | -78.11% | ||
Fundamentals | |||
Shares Outstanding | 124.5M | ||
Total Assets | $193.7M | ||
Market Cap | $163.1M | ||
Enterprise Value | $150.0M | ||
Period: QTR TTM FY | |||
Revenue | $238,000.00 | ||
Net Income | -$26.1M | ||
Free Cash Flow | -$16.1M | ||
EBIT | -$25.1M | ||
EBITDA | -$25.0M | ||
Net Working Capital | $171.3M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | 630 | ||
P/B | 5 | ||
P/E | -7 | ||
PEG | N/A | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue